|This Slide: #25 of 100|
Slide #25. Cumberland Pharmaceuticals — Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals (NASDAQ:CPIX)
Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced the acquisition of Vaprisol from Astellas Pharma US, Inc.
Cumberland Pharmaceuticals is a pharmaceutical company focused on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of chronic and acute constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
Open the CPIX Page at The Online Investor »
Free CPIX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Strong Buy (4.00 out of 4)